Cooper Companies Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 17, 2021 / 05:10PM GMT
Steven Michael Lichtman - Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

Hi, everyone. Sorry for the technical difficulties. This is Steve Lichtman, medical devices analyst at Oppenheimer. Welcome to the 31st Annual Oppenheimer Healthcare Conference. I'm very happy to have with us up next CooperCompanies. With us today is Dan McBride, Executive Vice President, COO and President of CooperVision; and Kim Duncan, Vice President, Investor Relations and Risk Management.

We're going to do this in a fireside format. If you have any questions, please key them in, and I will get them over to Dan and Kim. But with that, thank you both for joining us today.

Questions and Answers:

Steven Michael Lichtman - Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

Dan, I thought maybe we could talk a little bit to start off about the underlying contact lens market dynamics. You guys have pegged the market pretty consistently at a mid-single-digit level. There's multiple drivers. And I'm wondering if you can talk about
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot